Background: Surgical therapy for T2 glottic carcinoma still is a topic of controversial discussion. The value of laser therapy in this stage of disease is difficult to determine due to selection bias. Data of comparative analyses have usually been collected from retrospective studies which are more prone to selection bias. Patients and Methods: A total number of 14 patients suffering from T2 glottic carcinoma were treated by transoral laser microsurgery. Results: During the median follow-up of 24 months, 2 patients developed recurrent disease in the anterior commissure, and 12 patients remained free of disease. Conclusion: Endoscopic laser therapy should be considered after weighing up the indication thoroughly. The sometimes extremely difficult conditions in transoral laser surgery are tightly bound to the experience of the operating surgeon and in cases of doubt, conventional partial laryngectomy should be preferred.

Keywords:
T2 glottic carcinoma, Laser surgery, Squamous cell carcinoma
This content is only available via PDF.
© 2003 S. Karger AG, Basel
2003
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.